Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis

The sample sizes derived are in a range that makes MTR a feasible outcome measure for proof-of-concept trials of putative therapies achieving remyelination in MS lesions.